TY  - JOUR
AU  - Blasco, L
AU  - Bleriot, I
AU  - Gonzalez de Aledo, M
AU  - Fernandez-Garcia, L
AU  - Pacios, O
AU  - Oliveira, H
AU  - Lopez, M
AU  - Ortiz-Cartagena, C
AU  - Fernandez-Cuenca, F
AU  - Pascual, A
AU  - Martinez-Martinez, L
AU  - Pachon, J
AU  - Azeredo, J
AU  - Tomas, M
PY  - 2022
DO  - 10.1128/AAC.01923-21
UR  - http://hdl.handle.net/10668/20032
T2  - Antimicrobial agents and chemotherapy
AB  - The need for alternatives to antibiotic therapy due to the emergence of multidrug resistant bacteria (MDR), such as the nosocomial pathogen Acinetobacter baumannii, has led to the recovery of phage therapy. In addition, phages can be combined in...
LA  - en
PB  - American Society for Microbiology
KW  - Acinetobacter
KW  - Acinetobacter baumannii
KW  - Adaptation
KW  - Anti-biofilm.
KW  - Bacteriophages
KW  - Baumannii
KW  - Biofilms
KW  - Cocktail
KW  - Phages
KW  - Acinetobacter Infections
KW  - Bacteriophages
KW  - Biofilms
KW  - Genome, Viral
KW  - Genomics
KW  - Humans
TI  - Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the Host.
TY  - research article
VL  - 66
ER  -